Efficacy of adjuvant external beam radiotherapy and brachytherapy in squamous cell carcinoma of oral tongue: Long-term outcomes.

ABSTRACT:

Purpose

Squamous cell carcinoma of oral tongue (TSCC) poses a significant health challenge. Radiotherapy is the mainstay of treatment, with external beam radiotherapy (EBRT) and brachytherapy (BT) offering distinct advantages. This study investigated the long-term outcomes associated with each technique.

Material and methods

A retrospective analysis was done reviewing medical records of patients diagnosed with TSCC between 2012 and 2022, who underwent surgery and received adjuvant curative-intent radiotherapy. Patients were categorized based on treatment modality: EBRT alone, EBRT combined with brachytherapy (EBRT+ BT boost), or BT alone. Overall survival (OS) and disease-free survival (DFS) were evaluated at 5 years.

Results

A total of 84 patients were included, with

SUBMITTER: Shojaei S 

PROVIDER: S-EPMC11812135 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature